No issue with me! It's all just opinions. My main gist is that big Pharmas view things differently than we do. They don't need to jump in just before BoM results as if they really want it, they have the warchest to go after it if successful. Since we have only two main players showing interest right now does not mean that the big guys aren't lining up to pounce when their terms are met. As we know, Pfizer has shown interest on Zenith and could pounce any time. They, or others could be poised the same way for RVX but why do it so close to BoM Ph3 results? The months ahead will tell us who really is interested unless the unspeakable happens with BoM.